Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Caladrius Bio (NQ: CLBS ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 14, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 0.4202 (87) Ask (Size) 0.4210 (29) Prev. Close 0.4264 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 60,533,064 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday September 15, 2022 Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session September 14, 2022 Via Benzinga Performance More News Read More Caladrius Biosciences Stops Enrollment In Mid-Stage Heart Disease Study May 24, 2022 Via Benzinga Caladrius Biosciences To Merge With Privately-Held Cend Therapeutics April 27, 2022 Via Benzinga Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session September 14, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 02, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 02, 2022 Via InvestorPlace Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket September 02, 2022 Via Benzinga Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial August 10, 2022 Via Benzinga CALADRIUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS August 03, 2022 From Kahn Swick & Foti, LLC Via Business Wire Earnings Outlook For Caladrius Biosciences August 03, 2022 Via Benzinga Caladrius Biosciences's Earnings Outlook August 03, 2022 Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 02, 2022 Via Benzinga Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time July 28, 2022 From Caladrius Biosciences, Inc. Via GlobeNewswire The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures May 24, 2022 Via Benzinga CALADRIUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Caladrius Biosciences, Inc. - CLBS May 05, 2022 From Kahn Swick & Foti, LLC Via Business Wire 74 Biggest Movers From Yesterday April 29, 2022 Via Benzinga 48 Stocks Moving In Thursday's Mid-Day Session April 28, 2022 Via Benzinga 28 Stocks Moving in Thursday's Pre-Market Session April 28, 2022 Via Benzinga CLBS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Caladrius Biosciences, Inc. Is Fair to Shareholders April 27, 2022 From Halper Sadeh LLP Via Business Wire The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis April 27, 2022 Via Benzinga The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale March 23, 2022 Via Benzinga Recap: Caladrius Biosciences Q4 Earnings March 23, 2022 Via Benzinga The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout March 22, 2022 Via Benzinga Earnings Scheduled For March 22, 2022 March 22, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.